Skip to main content

Publications

2021

2020

2019

  • IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, Ikeda S, Shimada H, Minami N, Malhotra A, Morioka S, Ban Y, Asano M, Flanary VL, Ramkissoon A, Chow LML, Kiyokawa J, Mashimo T, Lucey G, Mareninov S, Ozawa T, Onishi N, Okumura K, Terakawa J, Daikoku T, Wise-Draper T, Majd N, Kofuji K, Sasaki M, Mori M, Kanemura Y, Smith EP, Anastasiou D, Wakimoto H, Holland EC, Yong WH, Horbinski C, Nakano I, DeBerardinis RJ, Bachoo RM, Mischel PS, Yasui W, Suematsu M, Saya H, Soga T, Grummt I, Bierhoff H, Sasaki AT. Nat Cell Biol. 2019 Aug;21(8):1003-1014. doi: 10.1038/s41556-019-0363-9. Epub 2019 Aug 1. PMID: 31371825; PMCID: PMC6686884.

2018

2017

2016

2015

2014

Prior to 2014

Contact Us

Vinita Takiar, MD, PhD
Department of Radiation Oncology
The Barrett Cancer Center
234 Goodman Street, ML 0757
Cincinnati, OH 45267-0757

Office: 513-584-1450
Email: takiarva@ucmail.uc.edu

Trisha Wise-Draper, MD, PhD
Department of Internal Medicine
University of Cincinnati College of Medicine
231 Albert Sabin Way, MSB Room 6065
Cincinnati, OH 45267-0557
Office: 513-558-2826
Email: wiseth@ucmail.uc.edu